产品详情
文献和实验
相关推荐
试剂
仪器
整体解决方案
耗材
优思达（USTAR）是一家致力于创新POCT分子诊断产品研发、生产和销售的高新生物科技公司。公司拥有多项自主知识产权和快速分子检测技术平台，其中包括：恒温扩增技术、全封闭式目标片段核酸扩增物快速检测技术和试剂玻璃化技术，并已在此平台上开发了多种新型快速分子诊断试剂盒。公司已经将这些技术融合为一， 开发出的全自动化平台使分子检测和诊断摆脱了对昂贵设备和分子实验室的依赖，让分子检测能方便、快速地在各级医疗、疾控和检测机构得以应用。优思达公司的快速分子检测技术已经得到比尔与梅琳达·盖茨基金会、世界卫生组织(WHO)、联合国儿童基金会、传染病防控非政府组织的广泛支持。其中“交叉引物恒温核酸扩增技术(CPA)”是中国具有自主知识产权的核酸扩增技术，据有广阔的市场应用前景。
Founded in 2005, Ustar is a leading provider of instant molecular diagnostic overall solution and has been focused on rapid nucleic acid diagnostic technology research and application innovation for more than 15 years. We have more than 200 employees, and we cover more 1000 hospitals and institutions in domestic, cooperate with China Customs, CDC, HUAWEI, COCACOLA, etc., exporting to more than 30 countries and regions.
Our vision and mission is to be the unique international biotechnology company in the fields of rapid molecular detection and diagnosis, and apply advanced diagnostic technology to the people. To this end, we are dedicated to build an instant molecular diagnostic system so that it could be performed at anywhere, not only all levels of medical facilities, but also public areas, companies, etc.
As the first POCT molecular diagnostics enterprise with dual certificates of equipment and reagent of Covid-19 in China, the fully automatic molecular diagnostic system only needs “One Step” operation to realize "sample in result out", without professional laboratory. And Ustar’s growing EasyNAT® test menu spans multiple clinical applications including Respiratory, Animal/Plant/Food safety, Nosocomial infection, Reproductive Health etc.
仪器
整体解决方案
耗材
优思达（USTAR）是一家致力于创新POCT分子诊断产品研发、生产和销售的高新生物科技公司。公司拥有多项自主知识产权和快速分子检测技术平台，其中包括：恒温扩增技术、全封闭式目标片段核酸扩增物快速检测技术和试剂玻璃化技术，并已在此平台上开发了多种新型快速分子诊断试剂盒。公司已经将这些技术融合为一， 开发出的全自动化平台使分子检测和诊断摆脱了对昂贵设备和分子实验室的依赖，让分子检测能方便、快速地在各级医疗、疾控和检测机构得以应用。优思达公司的快速分子检测技术已经得到比尔与梅琳达·盖茨基金会、世界卫生组织(WHO)、联合国儿童基金会、传染病防控非政府组织的广泛支持。其中“交叉引物恒温核酸扩增技术(CPA)”是中国具有自主知识产权的核酸扩增技术，据有广阔的市场应用前景。
Founded in 2005, Ustar is a leading provider of instant molecular diagnostic overall solution and has been focused on rapid nucleic acid diagnostic technology research and application innovation for more than 15 years. We have more than 200 employees, and we cover more 1000 hospitals and institutions in domestic, cooperate with China Customs, CDC, HUAWEI, COCACOLA, etc., exporting to more than 30 countries and regions.
Our vision and mission is to be the unique international biotechnology company in the fields of rapid molecular detection and diagnosis, and apply advanced diagnostic technology to the people. To this end, we are dedicated to build an instant molecular diagnostic system so that it could be performed at anywhere, not only all levels of medical facilities, but also public areas, companies, etc.
As the first POCT molecular diagnostics enterprise with dual certificates of equipment and reagent of Covid-19 in China, the fully automatic molecular diagnostic system only needs “One Step” operation to realize "sample in result out", without professional laboratory. And Ustar’s growing EasyNAT® test menu spans multiple clinical applications including Respiratory, Animal/Plant/Food safety, Nosocomial infection, Reproductive Health etc.
北京美科美生物技术开发有限公司
代理商实名认证
钻石会员
入驻年限：11年
